blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2046746

EP2046746 - CHEMICAL COMPOUNDS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.06.2014
Database last updated on 26.07.2024
Most recent event   Tooltip27.06.2014Application deemed to be withdrawnpublished on 30.07.2014  [2014/31]
Applicant(s)For all designated states
Praecis Pharmaceuticals Incorporated
830 Winter Street
Waltham, MA 02451-1420 / US
[2009/16]
Inventor(s)01 / EVINDAR, Ghotas
c/o GlaxoSmithKline 830 Winter Street Waltham
Boston Massachusetts 02451 / US
02 / DENG, Hongfeng
11 Brucewood Road
Acton, MA 01720 / US
03 / BERNIER, Sylvie
2 Maria Court
Woburn, MA 01801 / US
04 / YAO, Gang
20 Washbrook Rd.
Sudbury, MA 01776 / US
05 / COFFIN, Aaron
c/o GlaxoSmithKline 830 Winter Street Waltham
Boston Massachusetts 02451 / US
06 / YANG, Hongfang
8 Kimball Court, Apt. 308
Burlington, MA 01803 / US
 [2009/24]
Former [2009/16]01 / EVINDAR, Ghotas
31 Middlesex Circle, Apt. 19
Waltham, MA 02452 / US
02 / DENG, Hongfeng
11 Brucewood Road
Acton, MA 01720 / US
03 / BERNIER, Sylvie
2 Maria Court
Woburn, MA 01801 / US
04 / YAO, Gang
20 Washbrook Rd.
Sudbury, MA 01776 / US
05 / COFFIN, Aaron
57 Radnor Road, Apt. 1
Brighton, MA 02135 / US
06 / YANG, Hongfang
8 Kimball Court, Apt. 308
Burlington, MA 01803 / US
Representative(s)Wilkinson, Johanna Elise
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2012/44]Wilkinson, Johanna Elise
GlaxoSmithKline
Corporate Intellectual Property
(CN9.25.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Former [2009/16]Griffith, Johanna Elise
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date07836442.901.08.2007
[2009/16]
WO2007US17282
Priority number, dateUS20060821101P01.08.2006         Original published format: US 821101 P
US20060827919P03.10.2006         Original published format: US 827919 P
US20070896431P22.03.2007         Original published format: US 896431 P
US20070959291P12.07.2007         Original published format: US 959291 P
[2009/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008016692
Date:07.02.2008
Language:EN
[2008/06]
Type: A2 Application without search report 
No.:EP2046746
Date:15.04.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 07.02.2008 takes the place of the publication of the European patent application.
[2009/16]
Search report(s)International search report - published on:EP20.03.2008
ClassificationIPC:C07D213/38, C07D239/26, C07D261/08, C07D271/10, C07D277/28, C07D285/12, C07D417/12, C07F9/6539, A61K31/425, A61K31/433, A61K31/44, A61K31/505, A61P37/00
[2009/16]
CPC:
C07D277/28 (EP,US); C07D213/38 (EP,KR,US); A61K31/425 (KR);
A61P1/02 (EP); A61P1/04 (EP); A61P1/06 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P17/00 (EP);
A61P17/04 (EP); A61P17/06 (EP); A61P17/14 (EP);
A61P19/02 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/14 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/00 (EP); A61P37/06 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07D261/08 (EP,US);
C07D271/10 (EP,US); C07D285/12 (EP,KR,US); C07D417/12 (EP,US);
C07F9/58 (EP,US); C07F9/65031 (EP,US); C07F9/6512 (EP,US);
C07F9/653 (EP,US); C07F9/65312 (EP,US); C07F9/65318 (EP,US);
C07F9/6539 (EP,US); C07F9/65395 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/16]
Extension statesHR28.01.2009
TitleGerman:CHEMISCHE VERBINDUNGEN[2009/16]
English:CHEMICAL COMPOUNDS[2009/16]
French:COMPOSÉS CHIMIQUES[2009/16]
Entry into regional phase28.01.2009National basic fee paid 
28.01.2009Designation fee(s) paid 
28.01.2009Examination fee paid 
Examination procedure28.01.2009Examination requested  [2009/16]
21.12.2010Despatch of a communication from the examining division (Time limit: M06)
17.06.2011Reply to a communication from the examining division
01.03.2014Application deemed to be withdrawn, date of legal effect  [2014/31]
27.03.2014Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/31]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.12.2010
Fees paidRenewal fee
07.08.2009Renewal fee patent year 03
06.08.2010Renewal fee patent year 04
08.08.2011Renewal fee patent year 05
08.08.2012Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.08.201307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2006020951  (PRAECIS PHARM INC [US], et al) [X] 1-19 * claims 40-51; compounds 232-236 *;
 [E]WO2007092190  (PRAECIS PHARM INC [US], et al) [E] 1-19* claims 56-62; compounds 358-399 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.